Growth momentum KOELIS is actively expanding its reach in prostate cancer care through recent product launches such as ProMap Smart automatic prostate contouring software and ongoing participation in major conferences (AUA, EAU), indicating a sales opportunity to partner or upsell with clinics adopting MRI-ultrasound fusion workflows.

Global footprint With a presence spanning Europe, United States, Canada, Japan, Australia, South America and the Middle East and a multi-region activity cadence, there is a clear opportunity to target multilingual regional teams and leverage international case studies to drive adoption in new markets.

Clinical leadership KOELIS emphasizes advanced, multiparametric imaging and active surveillance support, collaborating with renowned universities and hospitals. This positions the company well for collaborations, training programs, and bundled offerings with high-volume urology and radiology centers seeking cutting-edge guidance.

Regulatory readiness The adoption of ISO 13485 and a focus on compliant, traceable imaging workflows suggests receptiveness to OEM partnerships, integrated service agreements, and potential channel partnerships with distributors seeking certified medical device solutions.

Workflow optimization Recent product updates such as compact 3D probes and automated contouring tools point to a value proposition around improved efficiency, reduced reprocessing time, and enhanced diagnostic confidence—key messaging for procurement teams prioritizing workflow ROI.